These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18088270)

  • 21. Epilepsy and the blood-brain barrier.
    Duncan R; Todd N
    Br J Hosp Med; 1991 Jan; 45(1):32-4. PubMed ID: 2009437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance in epilepsy: a pharmacogenomic update.
    Tate SK; Sisodiya SM
    Expert Opin Pharmacother; 2007 Jul; 8(10):1441-9. PubMed ID: 17661727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats.
    Shao Y; Wang C; Hong Z; Chen Y
    J Neurochem; 2016 Mar; 136(5):1096-105. PubMed ID: 26677173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy].
    Białecka M; Hnatyszyn G; Bielicka-Cymerman J; Droździk M
    Neurol Neurochir Pol; 2005; 39(6):476-81. PubMed ID: 16355305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.
    Marchi N; Guiso G; Caccia S; Rizzi M; Gagliardi B; Noé F; Ravizza T; Bassanini S; Chimenti S; Battaglia G; Vezzani A
    Neurobiol Dis; 2006 Dec; 24(3):429-42. PubMed ID: 17027274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy.
    Newman MJ; Dixon R; Toyonaga B
    Novartis Found Symp; 2002; 243():213-26; discussion 226-30, 231-5. PubMed ID: 11990779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predisposition to epilepsy--does the ABCB1 gene play a role?
    Nurmohamed L; Garcia-Bournissen F; Buono RJ; Shannon MW; Finkelstein Y
    Epilepsia; 2010 Sep; 51(9):1882-5. PubMed ID: 20491876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
    Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical reappraisal of the influence of drug-transporter polymorphisms in epilepsy.
    Orlandi A; Paolino MC; Striano P; Parisi P
    Expert Opin Drug Metab Toxicol; 2018 May; 14(5):505-512. PubMed ID: 29804481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDR1 gene expression in brain of patients with medically intractable epilepsy.
    Tishler DM; Weinberg KI; Hinton DR; Barbaro N; Annett GM; Raffel C
    Epilepsia; 1995 Jan; 36(1):1-6. PubMed ID: 8001500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug resistant epilepsy. Clinical and neurobiological concepts].
    Espinosa-Jovel CA; Sobrino-Mejía FE
    Rev Neurol; 2015 Aug; 61(4):159-66. PubMed ID: 26204087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
    Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
    Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal models of drug-resistant epilepsy.
    Löscher W
    Novartis Found Symp; 2002; 243():149-59; discussion 159-66, 180-5. PubMed ID: 11990774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intractable epilepsy and the P-glycoprotein hypothesis.
    Wang GX; Wang DW; Liu Y; Ma YH
    Int J Neurosci; 2016; 126(5):385-92. PubMed ID: 26000919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
    Potschka H; Löscher W
    Neuroreport; 2001 Aug; 12(11):2387-9. PubMed ID: 11496115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
    Ma A; Wang C; Chen Y; Yuan W
    Drug Des Devel Ther; 2013; 7():1447-54. PubMed ID: 24348021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The blood-brain barrier and epilepsy.
    Oby E; Janigro D
    Epilepsia; 2006 Nov; 47(11):1761-74. PubMed ID: 17116015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.